Oncolytics Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.

About ONCY

Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. 

CEO
Jared Kelly
CEOJared Kelly
Employees
29
Employees29
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
29
Employees29

ONCY Key Statistics

Market cap
109.59M
Market cap109.59M
Price-Earnings ratio
-3.53
Price-Earnings ratio-3.53
Dividend yield
Dividend yield
Average volume
1.09M
Average volume1.09M
High today
$1.08
High today$1.08
Low today
$0.89
Low today$0.89
Open price
$0.9382
Open price$0.9382
Volume
8.13M
Volume8.13M
52 Week high
$1.51
52 Week high$1.51
52 Week low
$0.77
52 Week low$0.77

Stock Snapshot

Oncolytics Biotech(ONCY) stock is priced at $0.91, giving the company a market capitalization of 109.59M. It carries a P/E multiple of -3.53.

As of 2026-07-13, Oncolytics Biotech(ONCY) stock has fluctuated between $0.89 and $1.08. The current price stands at $0.91, placing the stock +2.2% above today's low and -15.8% off the high.

The Oncolytics Biotech(ONCY)'s current trading volume is 8.13M, compared to an average daily volume of 1.09M.

In the last year, Oncolytics Biotech(ONCY) shares hit a 52-week high of $1.51 and a 52-week low of $0.77.

In the last year, Oncolytics Biotech(ONCY) shares hit a 52-week high of $1.51 and a 52-week low of $0.77.

ONCY News

TipRanks 5h
Oncolytics Biotech advances REO 033 colorectal cancer program

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...

Investing.com 9h
Oncolytics Biotech stock jumps on FDA meeting plans for trial - Investing.com

...

Oncolytics Biotech stock jumps on FDA meeting plans for trial - Investing.com
TipRanks 9h
Why Is Penny Stock Oncolytics Biotech Up Today?

Oncolytics Biotech (ONCY) stock was on the rise Monday alongside a clinical trial update from the clinical-stage biopharmaceutical company. The company provided...

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More ONCY News

TipRanks 9h
Oncolytics provides clinical, regulatory update on REO 033

Oncolytics (ONCY) provided a clinical and regulatory update on REO 033, the company’s randomized controlled study evaluating pelareorep in combination with foli...

People also own

Based on the portfolios of people who own ONCY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.